News Releases


Dec.12,2005 Agreement on Joint Development and Marketing of Rivastigmine Transdermal Patch for the Treatment of Alzheimer's Disease (95.5KB)
Dec.06,2005 Ono Enters Into Joint Development/Co-Marketing Agreement on an Additional Indication for Cervical Spondylosis of Limaprost Alfadex, an Oral Prostaglandin E1 Derivative Preparation, with Dainippon Sumitomo (17.1KB)
Nov.04,2005 Ono Entered Into Drug Discovery Agreement on Kinases with Array BioPharma Inc. (63.2KB)
Oct.25,2005 Patient Enrollment for Phase III Clinical Studies with New HIV Drug (ONO-4128 / 873140) Terminated (101KB)
Sep.20,2005 Changes to the Development Program for ONO-4128 / 873140 (48.8KB)
Aug.10,2005 Development status of ONO-2506PO/Cereact® Capsules (69.6KB)
Jul.25,2005 Development Status Update of ONO-4128/873140 (7.9KB)
Jun.13,2005 Results of Phase II Studies of Sitagliptin (MK-0431 / ONO-5345) Investigational Treatment for Type 2 Diabetes Presented by Merck & Co., Inc. at ADA (33.4KB)
May.26,2005 Development Status of ONO-2506 for Injection/PROGLIA (9.3KB)
May.18,2005 Announcement concerning Changes of Representative Directors (49.9KB)
May.12,2005 Ono and Medarex Enter Into Collaborative Research Agreement on Antibody Product (53.2KB)
Apr.28,2005 Ono resolved increase in dividends projected for the fiscal year 2004(ending on March 31,2005) (146KB)
Apr.28,2005 Ono Pharmaceutical Announces Dissolution of a Subsidiary (16.9KB)
Mar.01,2005 New Data on New HIV Drug(Oral CCR5 Receptor Antagonist) (21.8KB)
Feb.28,2005 Development Status of ONO-2506 for Injection/PROGLIA outside Japan and Development Plan of Compounds in-licensed from Merck in Japan (97.5KB)
Jan.11,2005 Opening of a Contributed Chair at Kyoto University, Graduate School of Medicine and Faculty of Medicine (8.7KB)